Good questions I'm still stuck on Q1. I note other enthusiastic...

First 34 Last

Share
Profile

Follow
Koskal

11 Posts.

02/05/17

13:36

Post #: 24410850
Share

Originally posted by dirtyharry76 ↑

1. Didn't they just sell the part of the business that generates the revenue (which as it happens was <$10m and falling year-on-year based on last year's results)?
2. They raised $3m to open these offices in 2016 ('In October 2016 the Group received a total of $3,000,000 from the issue of shares to pursue the international distribution strategy for EnviroSuite"). Seems that it would not be too hard to establish "An international presence" when you're spending investors dough to do it?
3. Isn't this yet to be proven? Lots of startups talk of "pipelines". There doesn't seem to be too many revenue generating contracts announced for the Envirosuite product (which is all that EVS has after this sale isn't it?).
4. Tick. But there are (and have been) plenty of businesses that have failed to deliver on SaaS models.
5. Why is B2B is necessarily better than consumer revenue?
6. On what basis is this applicable to EVS post-sale of consulting business (or pre-sale of consulting business for that matter)?
7. Isn't that fundamentally what SaaS businesses are about?
8. How do we know that?
9. No way that can be known yet. EVS post-this-sale is a complete unknown.
10. Do they?

Expand

Good questions I'm still stuck on Q1. I note other enthusiastic posts and really hope they are right but I dont understand how EVS post sale can be priced at present? As a novice I cant remember seeing an independent view on market potential for EVS, no significant forecast data. No objective data (eg spend on BD to conversion to a contract win ratios). Can a stock be priced based on dot points of companies that may be interested in the field of air pollution forecasting ?

EVS Price at posting: 6.9¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dreadnought achieves 84% indicated resource at Star of Mangaroon

There are more pages in this discussion • 8 more messages in this thread...

First 34 Last

Add EVS (ASX) to my watchlist

(20min delay)
Last 5.2¢		Change -0.002(3.70%)		Mkt cap ! $99.87M

Open	High	Low	Value	Volume
5.3¢	5.3¢	5.1¢	$125.4K	2.416M

Buyers (Bids)

No.	Vol.	Price($)
2	737406	5.1¢

Sellers (Offers)

Price($)	Vol.	No.
5.3¢	46363	1

View Market Depth

No.	Vol.	Price($)
2	31009	0.160
1	74247	0.155
10	742532	0.150
7	544595	0.145
4	319049	0.140

Price($)	Vol.	No.
0.165	126720	2
0.170	625000	3
0.175	120000	1
0.180	68832	2
0.185	140908	2

Last trade - 16.10pm 26/11/2024 (20 minute delay)

EVS (ASX) Chart

Good questions I'm still stuck on Q1. I note other enthusiastic...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dreadnought achieves 84% indicated resource at Star of Mangaroon

Buyers (Bids)

Sellers (Offers)